Navigation Links
Bel Marra Health Reports on a New Study: Software Originally Used for Star Gazing Now Being Used to Analyze Breast Cancer Tissue
Date:3/3/2013

Toronto, ON (PRWEB) March 03, 2013

Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, is reporting on a new research that shows the success of software originally used for star gazing and how it is now being used to analyze breast cancer tissue.

As Bel Marra Health reports in its article (http://www.belmarrahealth.com/cancer/star-gazing-software-and-breast-cancer/) one of the most common procedures involved in the diagnosis of cancer of the breast involves getting a small tissue sample or biopsy from the breast and subjecting these to different staining methods.

These special stains allow the pathologist to identify specific proteins, such as the estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and B-cell lymphoma 2 (BCL2), which provide information on the patient’s response to cancer treatment. At the same time, these stains help the pathologist determine the actual breast cancer stage of a patient. The information provided by histopathological staining allows the oncologist to design a cancer treatment scheme for the patient.

Although the staining procedure seems relatively simple and straightforward, those working in the pathology laboratories are often faced with problems relating to biopsy processing. First, these biopsy specimens need to be processed within a few hours of removal from the breast because these tissue proteins are very delicate and easily react to external conditions.

Second, certain proteins in the breast tissue are difficult to analyze using current staining procedures. It may be possible to obtain high-quality staining using tissue samples from one patient, but that does not assure the pathologist that the same results will be observed in the tissue of the next patient.

As the Bel Marra Health article reads, according to a recent medical report published in the British Journal of Cancer, the analysis of stained tissues from patients with breast cancer may now be analyzed using an imaging software that was originally designed for star gazing. Astronomers are also faced with challenges involving visualization of tiny illuminated bodies in the vast, dark sky, often requiring powerful equipment to capture those stars and planets from afar. In turn, pathologists are also faced with challenges of detecting tiny stained proteins in breast tissues. Both areas of specialization thus need technologies that would help not only visualize small entities but also process these types of information in a rapid and reliable way.

The investigators employed the astronomy-based imaging software in screening approximately 2,268 breast cancer tissues that were previously subjected to standard tissue staining techniques. These tissues were analyzed using the same proteins, ER, HER2, and BCL2, and compared with the information generated from manual staining procedures.

The results of the study showed that the astronomical software provided the same screening precision in identifying the three proteins. More importantly, this star gazing software was able to process all the samples as a significantly faster rate than the manual approach.

The results of this study showed that this imaging software that was originally used for visualizing stars and planets might also be applied in the clinics. The information generated by this software is as reliable as that produced by manual microscopic analysis of stained tissues. Based on the rapid turnover of results of this new technology, it may thus be possible to analyze a larger number of tissues in a shorter amount of time; this may hopefully assist in the diagnosis of cancer and in the design of cancer treatment schemes.

(SOURCE: Ali HR, Irwin M, Morris L, Dawson SJ, Blows FM, Provenzano E, Mahler-Araujo B, Pharoah PD, Walton NA, Brenton JD, Caldas C. Astronomical algorithms for automated analysis of tissue protein expression in breast cancer. Br J Cancer. 2013 Feb 19;108(3):602-12. doi: 10.1038/bjc.2012.558.)

Bel Marra Health is the maker of “Heart Rescue” a high-quality nutritional supplement designed for heart health in formulations designed to address this specific health concern. All ingredients are backed with scientific evidence. Every product is tested for safety, quality, and purity at every stage of the manufacturing process. Furthermore, Bel Marra Health products are produced only in Health Canada approved facilities, going that extra mile to ensure our health conscious customers are getting top quality products. For more information on Bel Marra Health visit http://www.belmarrahealth.com or call 1-866-531-0466.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10487930.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bel Marra Health Reports on a New Study: Mixed Weight Couples are More Likely to Have Unhappy Marriages
2. Bel Marra Health Reports on a New Study: Body Image Influences Psychosocial Activities and Quality of Life.
3. You Survived Cancer: Now Pay Attention to Your Overall Health
4. NIH awards $20 million over 5 years to train next generation of global health researchers
5. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
6. Esophageal Cancer Surgery Can Leave Lingering Health Problems, Study Says
7. Climate Change Could Be Tough on Seniors Health: Study
8. Supporting LGB children may influence their long-term health, BU study finds
9. U.S. Spends Too Little on Public Health Initiatives: Report
10. Optimal care of bariatric surgery patients vital for long-term health and well-being
11. Timing pregnancy an important health concern for women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... The threat ... went to work for a company involved in the underground testing of nuclear weapons. ... “Dying for Answers: Expendable Workers of the Cold War Nuclear Testing,” Clayton exposes the ...
(Date:2/27/2017)... ... , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the International Lyme and ... for Disease Control ( CDC ) and Infectious Diseases Society of America (IDSA) dismiss ... compiled into a single volume a compelling argument that the disease does exist in ...
(Date:2/27/2017)... ... February 27, 2017 , ... New Jersey ranks among the top five ... genders. And the need for advanced services is growing. , Project WE vs ... program, in collaboration with their non-profit partners in their fight against cancer and in ...
(Date:2/26/2017)... ... February 26, 2017 , ... LatitudeC ... North America, today announced it would be offering some it’s exclusive product line ... on crafting quality and unique baby clothing/feeding products, will team up with AMAZON ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... (PD) in persons with a specific LRRK2 mutation, according to a study released ... studies have provided evidence of a link between pesticides and incidence of sporadic ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Feb. 27, 2017  A landmark study ... , MBBS, PhD, FRACS, of  Sydney Heart and ... Sydney will be published in the February 28, ... American College of Cardiology . According to the study, which ... bypass surgery technique (anOPCABG) reduced postoperative stroke ...
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... ROCKVILLE, Md. , Feb. 27, 2017 /PRNewswire/ ... "RegeneRx"), a clinical-stage drug development company focused on ... its licensee for RGN-137, GtreeBNT Co., Ltd., received ... its Phase 3 clinical trial design for RGN-137 ... dermal wound healing gel that incorporates Thymosin beta ...
Breaking Medicine Technology: